Neuroprotective effects of piperine, an alkaloid from the Piper genus, on the Parkinson's disease model in rats

Journal Title: Journal of Neurology and Therapeutics - Year 2015, Vol 1, Issue 1

Abstract

Piperine (PIP), an alkaloid from the Piper genus plants, presents biological properties, including potent anti-inflammatory actions. Since neuroinflammation plays a key role in Parkinson's disease (PD), the objectives were to evaluate the neuroprotective activity of PIP in a model of PD. Male Wistar rats were divided as: sham-operated (SO), untreated 6-OHDA (lesioned in the right striatum) and 6-OHDA lesioned and treated orally with PIP (5 and 10 mg/kg, 2 weeks). The SO group was injected with saline into the right striatum. The SO and untreated 6-OHDA groups were administered with water, for 2 weeks. All animals were subjected to behavioral (open field, rotarod, and apomorphine-induced rotations tests), neurochemical (DA and DOPAC determinations), histological (fluoro jade staining) and immunohistochemical analyses (TH, DAT, TNF-alpha and iNOS). The results showed that PIP reversed behavioral alterations observed in the untreated 6-OHDA group. DA and DOPAC contents decreased in the striatal lesioned side of the untreated 6-OHDA group, but this change was in part reversed by PIP, at the higher dose. The fluoro jade fluorescence, observed in the untreated 6-OHDA group was attenuated after PIP treatments. Furthermore, increased immunoreactivities for TH and DAT were completely reversed in the lesioned group after PIP treatments. In addition, a partial recovery of increased striatal immunoreactivies for TNF-alpha and iNOS was observed in the lesioned group after PIP treatments. In conclusion, PIP presented a neuroprotective action, probably a consequence of its anti-inflammatory and antioxidant properties, making the drug a potential candidate for the treatment of neurodegenerative diseases as PD.

Authors and Affiliations

Correia AO, Cruz AAP, Aquino ATRD, Diniz JRG, Santana KBF, Cidade PIM, Peixoto JD, Lucetti DL, Nobre MEP, Neves KRT, Viana GSDB

Keywords

Related Articles

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids: Case report and review of the literature

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is a brainstem-predominant encephalomyelitis first described by Pittock and colleagues in 2010. CLIPPERS presents w...

Could overmedication associated with spinal injuries be treated with one more CNS drug?

Overmedication is a common problem generally associated with the aging population suffering typically of one or several chronic diseases. However, side effects, drug interactions and excessive use of multiple drug treatm...

Spine metastasis from glioblastoma multiforme: A case report

Primary brain and CNS tumor incidence is approximately seven per 100,000 individuals per year worldwide. Glioblastoma multiforme metastasis outside the CNS are extremely rare, occurring in <2% of patients, so therapeutic...

Neuromyelitis optica spectrum disorders with and without aquaporin 4 antibody: Characterization, differential diagnosis, and recent advances

Importance: The term neuromyelitis optica spectrum disorders (NMOSD) currently includes neuromyelitis optica (NMO) and rare neurological disorders characterized by specific IgG autoantibodies directed against aquaporin 4...

Neuroprotective effects of piperine, an alkaloid from the Piper genus, on the Parkinson's disease model in rats

Piperine (PIP), an alkaloid from the Piper genus plants, presents biological properties, including potent anti-inflammatory actions. Since neuroinflammation plays a key role in Parkinson's disease (PD), the objectives we...

Download PDF file
  • EP ID EP560485
  • DOI 10.14312/2397-1304.2015-1
  • Views 24
  • Downloads 0

How To Cite

Correia AO, Cruz AAP, Aquino ATRD, Diniz JRG, Santana KBF, Cidade PIM, Peixoto JD, Lucetti DL, Nobre MEP, Neves KRT, Viana GSDB (2015). Neuroprotective effects of piperine, an alkaloid from the Piper genus, on the Parkinson's disease model in rats. Journal of Neurology and Therapeutics, 1(1), 1-8. https://europub.co.uk/articles/-A-560485